Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma

Fig. 2

Differences in clinical prognosis between the low and high DRD1 expression groups. a OS analysis indicated that low DRD1 expression indicates a poor prognosis. b The RFS curve indicated that low DRD1 expression is associated with shorter RFS time. c The high DRD1 expression group had better PFS than the low expression group. d The high DRD1 expression group had better DSS than the low expression group

Back to article page